These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19079079)

  • 1. Lewy body pathology in long-term fetal nigral transplants: is Parkinson's disease transmitted from one neural system to another?
    Kordower JH; Brundin P
    Neuropsychopharmacology; 2009 Jan; 34(1):254. PubMed ID: 19079079
    [No Abstract]   [Full Text] [Related]  

  • 2. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.
    Kordower JH; Chu Y; Hauser RA; Freeman TB; Olanow CW
    Nat Med; 2008 May; 14(5):504-6. PubMed ID: 18391962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuromythology of Parkinson's Disease.
    Calne DB; Mizuno Y
    Parkinsonism Relat Disord; 2004 Jul; 10(5):319-22. PubMed ID: 15196512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients.
    Cooper O; Astradsson A; Hallett P; Robertson H; Mendez I; Isacson O
    J Neurol; 2009 Aug; 256 Suppl 3():310-6. PubMed ID: 19711122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.
    Tompkins MM; Basgall EJ; Zamrini E; Hill WD
    Am J Pathol; 1997 Jan; 150(1):119-31. PubMed ID: 9006329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are Lewy bodies non-specific epiphenomena of nigral damage?
    Wenning G; Quinn N
    Mov Disord; 1994 May; 9(3):378-9. PubMed ID: 8041389
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
    Li JY; Englund E; Widner H; Rehncrona S; Björklund A; Lindvall O; Brundin P
    Mov Disord; 2010 Jun; 25(8):1091-6. PubMed ID: 20198645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lewy body pathology in fetal grafts.
    Chu Y; Kordower JH
    Ann N Y Acad Sci; 2010 Jan; 1184():55-67. PubMed ID: 20146690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathology of fetal nigral grafts in patients with Parkinson's disease.
    Kordower JH; Freeman TB; Olanow CW
    Mov Disord; 1998; 13 Suppl 1():88-95. PubMed ID: 9613724
    [No Abstract]   [Full Text] [Related]  

  • 12. Nigral and extranigral pathology in Parkinson's disease.
    Braak H; Braak E; Yilmazer D; Schultz C; de Vos RA; Jansen EN
    J Neural Transm Suppl; 1995; 46():15-31. PubMed ID: 8821039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of Parkinson's disease 2008].
    Deuschl G
    MMW Fortschr Med; 2008 May; 150 Suppl 2():60-3. PubMed ID: 18678055
    [No Abstract]   [Full Text] [Related]  

  • 14. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
    Tsuboi Y; Dickson DW
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.
    Iannaccone S; Cerami C; Alessio M; Garibotto V; Panzacchi A; Olivieri S; Gelsomino G; Moresco RM; Perani D
    Parkinsonism Relat Disord; 2013 Jan; 19(1):47-52. PubMed ID: 22841687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The mechanism of Lewy body formation in Parkinson's disease].
    Wakabayashi K; Takahashi H
    Nihon Rinsho; 2000 Oct; 58(10):2022-7. PubMed ID: 11068441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal nigral transplantation as a therapy for Parkinson's disease.
    Olanow CW; Kordower JH; Freeman TB
    Trends Neurosci; 1996 Mar; 19(3):102-9. PubMed ID: 9054056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep brain stimulation in Parkinson's disease following fetal nigral transplantation.
    Herzog J; Pogarell O; Pinsker MO; Kupsch A; Oertel WH; Lindvall O; Deuschl G; Volkmann J
    Mov Disord; 2008 Jul; 23(9):1293-6. PubMed ID: 18536037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive potential of fetal nigral implants for Parkinson disease.
    Landau WM
    Arch Neurol; 2004 Nov; 61(11):1808-9. PubMed ID: 15534196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.